Correlation between miR-27 rs895819 and miR-423 rs6505162 Polymorphisms and Susceptibility to Colorectal Cancer in the Iranian Population: A Case-Control Study
Objectives: MicroRNAs play a vital role in biological processes, and their irregularities have been associated with colorectal cancer (CRC) development. This study utilized a case-control method to investigate the possible link between two particular miRNA variations, mir-27a rs895819 and mir-423 rs6505162, and CRC susceptibility in the Iranian population.
Methods: This case-control study included 120 CRC patients and 120 healthy individuals. Genotyping of the mir-27a rs895819 and mir-423 rs6505162 polymorphisms was performed using the PCR-RFLP method. The odds ratio (OR) and 95% confidence interval (95% CI) were calculated to evaluate the correlations.
Results: No significant disparities were detected between the cases and controls regarding age, gender, BMI, family history of CRC, and residency. The analysis indicated that the GG genotype of the mir-27a rs895819 polymorphism was notably linked to a higher CRC risk (OR=2.134, 95% CI 1.008-4.517, p=0.048). Nevertheless, no substantial connection was noted between the mir-423 rs6505162 polymorphism and CRC susceptibility.
Conclusion: The study results indicate that the mir-27a rs895819 polymorphism could serve as a potential biomarker for CRC progression. However, no correlation was found for the mir-423 rs6505162 polymorphism. Further research with diverse ethnic groups and larger sample sizes is necessary to confirm the link between these polymorphisms and CRC development
1. Vakili M, Shirinzadeh-Dastgiri A, Ershadi R, Dastgheib SA, Shiri A, Aghasipour M, et al. Correlation between rs1800871, rs1800872 and rs1800896 polymorphisms at IL-10 gene and lung cancer risk. Asian Pac J Cancer Prev 2024;25:287–98.
2. Gholi-Nataj M, Rafieian S, Barahman M, Shirinzadeh-Dastgiri A, Vakili M, Ershadi R, et al. A meta-analysis for prevalence of lung cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic. Eurasian J Med Oncol 2022;6:73–82.
3. Moshtaghioun SM, Fazel-Yazdi N, Mandegari M, ShirinzadehDastgiri A, Vakili M, Fazel-Yazdi H. Evaluation the presence of SERPINA5 (Exon 3) and FTO rs9939609 polymorphisms in papillary thyroid cancer patients. Asian Pac J Cancer Prev 2021;22:3641–3646.
4. Bebington B, Singh E, Fabian J, Jan Kruger C, Prodehl L, Surridge D, et al. Design and methodology of a study on colorectal cancer in Johannesburg, South Africa. JGH Open 2018;2:139–43.
5. Sayad S, Karimi-Zarchi M, Sayad S, Vakili M, ShirinzadehDastgiri A, Naseri A, et al. A collect of recommendations and guidelines for management and treatment of underlying malignancies during the COVID-19 pandemic. Acta Med Iran 2023;61:443–48.
6. Jafari-Nedooshan J, Dastgheib SA, Kargar S, Zare M, RaeeEzzabadi A, Heiranizadeh N, et al. Association of IL-6 -174 G>C polymorphism with susceptibility to colorectal cancer and gastric cancer: A systematic review and meta-analysis. Acta Med (Hradec Kralove) 2019;62:137–46.
7. Ghelmani Y, Asadian F, Antikchi MH, Dastgheib SA, Shaker SH, Jafari-Nedooshan J, et al. Association between the hOGG1 1245C>G (rs1052133) polymorphism and susceptibility to colorectal cancer: A meta-analysis based on 7010 cases and 10,674 controls. J Gastrointest Cancer 2021;52:389–98.
8. Kastrinos F, Syngal S. Inherited colorectal cancer syndromes. Cancer J 2011;17:405–15.
9. Mirjalili SA, Moghimi M, Aghili K, Jafari M, Abolbaghaei SM, Neamatzadeh H, et al. Association of promoter region polymorphisms of interleukin-10 gene with susceptibility to colorectal cancer: A systematic review and meta-analysis. Arquivos Gastroenterol 2018;55:306–13.
10. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer inci dence and mortality. Gut 2017;66:683–91.
11. Mannucci A, Zuppardo RA, Rosati R, Di Leo M, Perea J, Cavestro GM. Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis. World J Gastroenterol 2019;25:2565– 80.
12. Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: A review article. Iran J Public Health 2018;47:309–16.
13. Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: A systematic review and meta-analysis Chronic Disease epidemiology. BMC Public Health 2015;15:997.
14. Saadati HM, Okhovat B, Khodamoradi F. Incidence and risk factors of colorectal cancer in the iranian population: A systematic review. J Gastrointest Cancer 2021;52:414–21.
15. Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in Iran: Molecular epidemiology and screening strategies. J Cancer Epidemiol 2015;2015:643020.
16. Huguet JM, Suárez P, Ferrer-Barceló L, Ruiz L, Monzó A, Durá AB, et al. Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: Review of general recommendations. World J Gastrointes Endosc 2017;9:255–62.
17. Mousavi A, Karimi Zarchi M, Gilani MM, Behtash N, Ghaemmaghami F, Shams M, et al. Radical hysterectomy in the elderly. World J Surg Oncol 2008;6:38.
18. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009;125:171–80.
19. Vieira AR, Abar L, Chan DSM, Vingeliene S, Polemiti E, Stevens C, et al. Foods and beverages and colorectal cancer risk: A systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol 2017;28:1788–802.
20. Motamedi S, Majidzadeh K, Mazaheri M, Anbiaie R, Mortazavizadeh SM, Esmaeili R. Tamoxifen resistance and CYP2D6 copy numbers in breast cancer patients. Asian Pac J Cancer Prev 2012;13:6101–4.
21. Jensen BW, Gamborg M, Gögenur I, Renehan AG, Sørensen TIA, Baker JL. Childhood body mass index and height in relation to site-specific risks of colorectal cancers in adult life. Eur J Epidemiol 2017;32:1097–106.
22. Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ. Cancer risk among people with type 1 and type 2 diabetes: Disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264–70.
23. Razmpoosh E, Safi S, Mazaheri M, Salehi-Abargouei A, Abdollahi N, Nazari M, et al. Effects of oral Nigella sativa oil on the expression levels and serum concentrations of adiponectin, PPAR-γ, and TNF-α in overweight and obese women: A study protocol for a crossover-designed, double-blind, placebocontrolled randomized clinical trial. Trials 2019;20:512.
24. Peters U, Bien S, Zubair N. Genetic architecture of colorectal cancer. Gut 2015;64:1623–36.
25. Safi S, Razmpoosh E, Fallahzadeh H, Mazaheri M, Abdollahi N, Nazari M, et al. The effect of Nigella sativa on appetite, anthropometric and body composition indices among overweight and obese women: A crossover, double-blind, placebocontrolled, randomized clinical trial. Complement Ther Med 2021;57:102653.
26. Yamagishi H, Kuroda H, Imai Y, Hiraishi H. Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer 2016;35:4.
27. Mazaheri M, Shahdadi V, Nazari Boron A. Molecullar and biochemical effect of alcohlic extract of Alpinia galanga on rat spermatogenesis process. Iran J Reprod Med 2014;12:765–70.
28. Liu H, Lei C, He Q, Pan Z, Xiao D, Tao Y. Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol Cancer 2018;17:64.
29. Khodadadian A, Hemmati-Dinarvand M, Kalantary-Charvadeh A, Ghobadi A, Mazaheri M. Candidate biomarkers for Parkinson's disease. Biomed Pharmacother 2018;104:699–704.
30. Kabiri Rad H, Mazaheri M, Dehghani Firozabadi A. Relative expression of PBMC MicroRNA-133a analysis in patients receiving warfarin after mechanical heart valve replacement. Avicenna J Med Biotechnol 2018;10:29–33.
31. Shu J, Silva BVRE, Gao T, Xu Z, Cui J. Dynamic and modularized MicroRNA regulation and its implication in human cancers. Sci Rep 2017;7:13356.
32. Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: An overview of nuclear functions. Int J Mol Sci 2016;17:1712.
33. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843–54.
34. Parra-Medina R, López-Kleine L, Ramírez-Clavijo S, PayánGómez C. Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis. Sci Rep 2020;10:12345.
35. Moody L, Dvoretskiy S, An R, Mantha S, Pan YX. The efficacy of miR-20a as a diagnostic and prognostic biomarker for colorectal cancer: A systematic review and meta-analysis. Cancers (Basel) 2019;11:1111.
36. Mashhadiabbas F, Neamatzadeh H, Nasiri R, Foroughi E, Farahnak S, Piroozmand P, et al. Association of vitamin D receptor BsmI, TaqI, FokI, and ApaI polymorphisms with susceptibility of chronic periodontitis: A systematic review and meta-analysis based on 38 case -control studies. Dent Res J (Isfahan) 2018;15:155–65.
37. Khan AA, Agarwal H, Reddy SS, Arige V, Natarajan B, Gupta V, et al. MicroRNA 27a is a key modulator of cholesterol biosyn thesis. Mol Cell Biol 2020;40:e00470–19.
38. Alvarez ML, Khosroheidari M, Eddy E, Done SC. MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis. Atherosclerosis 2015;242:595–604.
39. Li X, Xu M, Ding L, Tang J. MiR-27a: A novel biomarker and potential therapeutic target in tumors. J Cancer 2019;10:2836– 48.
40. Jia W, Zeng L, Luo S, Bai F, Zhong R, Wu L, et al. Association of microRNA-423 rs6505162 C>A polymorphism with susceptibility and metastasis of colorectal carcinoma. Medicine (Baltimore) 2018;97:e9846.
41. Falvella FS, Cheli S, Martinetti A, Mazzali C, Iacovelli R, Maggi C, et al. DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan. Br J Clin Pharmacol 2015;80:581– 588.
42. Yin J, Wang X, Zheng L, Shi Y, Wang L, Shao A, et al. Hsa-miR- 34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. PLoS One 2013;8:e80570.
43. Xing J, Wan S, Zhou F, Qu F, Li B, Myers RE, et al. Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2012;21:217–27.
44. Liu Q, Li D, Dai Y, Zhang Y, Lan S, Luo Q, et al. Functional gene polymorphisms and expression alteration of selected microRNAs and the risk of various gastric lesions in Helicobacter pylori-related gastric diseases. Front Genet 2023;13:1097543.
45. Zhang S, Han Q, Zhu K, Wang Q. The association of miR-27a rs895819 polymorphism with colorectal cancer risk in Chinese population. J Clin Lab Anal 2020;34:e23497.
46. Xu Q, Chen TJ, He CY, Sun LP, Liu JW, Yuan Y. MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori. Sci Rep 2017;7:41307.
47. Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics 2019;11:25.
48. Khamirani HJ, Zoghi S, Faghihi F, Dastgheib SA, Hassanipour H, Bagher Tabei SM, et al. Phenotype of ST3GAL3 deficient patients: A case and review of the literature. Eur J Med Genet 2021;64:104250.
49. Guo X, Zhao L, Shen Y, Shao Y, Wei W, Liu F. Polymorphism of miRNA and esophageal cancer risk: An updated systemic review and meta-analysis. Onco Targets Ther 2019;12:3565–580.
50. Lu J, Clark AG. Impact of microRNA regulation on variation in human gene expression. Genome Res 2012;22:1243–54.
51. Ahmad S, Reza E, Abdolhamid A, Jamal J, REZA SH, Shadi K, et al. Severe main bronchus obstruction due to pulmonary schwannoma: A case report. Iran J Ped Hematol Oncol 2022;12:140–4.
52. Poorang S, Abdollahi S, Anvar Z, Tabei SMB, Jahromi BN, Moein-Vaziri N, et al. The impact of Methylenetetrahydrofolate Reductase (MTHFR) sperm methylation and variants on semen parameters and the chance of recurrent pregnancy loss in the couple. Clin Lab 2018;64:1121–8.
53. Zhang H, Zhang Y, Zhao X, Ma X, Yan W, Wang W, et al. Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer. Oncotarget 2017;8:46969–80.
54. Kargar S, Dalimi A, Eslami G, Hajimohammadi B, Shirinzadeh A, Amouei A, et al. Cystic echinococcosis in central Iran: G1 and G6 genotypes in patients. Surg Infect (Larchmt) 2022;23:451– 7.
55. Babakhanzadeh E, Khodadadian A, Nazari M, Dehghan Tezerjani M, Aghaei SM, Ghasemifar S, et al. Deficient expression of DGCR8 in human testis is related to spermatogenesis dysfunction, especially in Meiosis I. Int J Gen Med 2020;13:185–92.
56. Hakimian M, Ghorbian S. Negative associations between the has-miR-27a and hsa-miR-125a gene variations and prostate cancer susceptibility. Mol Biol Rep 2020;47:4209–14.
57. Yang X, Li X, Hao X, Tian W, Zhou B. Association of miR-27a polymorphism with the risk of digestive system cancers. Pathol Res Pract 2020;216:153115.
58. Barisciano G, Colangelo T, Rosato V, Muccillo L, Taddei ML, Ippolito L, et al. miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. Br J Cancer 2020;122:1354–66.
59. Su C, Huang DP, Liu JW, Liu WY, Cao YO. miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1. Oncol Lett 2019;18:2825–34.
60. Yuan L, Zhang TT, Ren Y. miR-27a rs895819 polymorphism and risk of cancer in Chinese population: A meta-analysis. J Evid Based Med 2015;8:75–83.
61. Dai J, Chen Y, Gong Y, Gu D, Chen J. Association of microRNA- 27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis. Gene 2020;728:144185.
62. Kupcinskas J, Bruzaite I, Juzenas S, Gyvyte U, Jonaitis L, Kiudelis G, et al. Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer. Sci Rep 2014;4:5993.
63. Ke R, Lv L, Zhang S, Zhang F, Jiang Y. Functional mechanism and clinical implications of MicroRNA-423 in human cancers. Cancer Med 2020;9:9036–51.
64. Moazeni-Roodi A, Ghavami S, Hashemi M. Association between miR-423 rs6505162 polymorphism and susceptibility to cancer. Arch Med Res 2019;50:21–30.